
Charles Schwab Corporation ownership: holders and insider trading
$92.98+1.37%Close 13 Nov 2026 · Market value $161.9B
As filed, its directors and officers own 6.3% of the shares (proxy statement, 3 Mar 2026); 2,308 institutional managers reported holding 83.6% at 30 Jun 2026. Over the last twelve months, insiders bought $1.85M and sold $346.8M of shares on the open market, $35.32M of it under 10b5-1 plans set in advance.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Vanguard | Institution | 151M | 8.76%* | Form 13F | 30 Jun 2026 |
|---|
| Blackrock, Inc. | Holder | 134M | 7.79%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 125M | 7.18% | Schedule 13G | 31 Mar 2026 |
|---|
| Charles R. Schwab | Insider | 103M | 5.9% | Proxy statement | 3 Mar 2026 |
|---|
| Dodge & Cox | Institution | 77.0M | 4.46%* | Form 13F | 30 Jun 2026 |
|---|
| State Street | Institution | 73.2M | 4.24%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 49.2M | 2.85%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 44.3M | 2.56%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 43.3M | 2.51%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 37.3M | 2.16%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 36.5M | 2.11%* | Form 13F | 30 Jun 2026 |
|---|
| Primecap Management Co | Institution | 25.1M | 1.46%* | Form 13F | 30 Jun 2026 |
|---|
| Harris Associates L P | Institution | 24.2M | 1.40%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 22.8M | 1.32%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 22.7M | 1.31%* | Form 13F | 30 Jun 2026 |
|---|
| Fisher Asset Management, LLC | Institution | 22.0M | 1.27%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 21.5M | 1.24%* | Form 13F | 30 Jun 2026 |
|---|
| Artisan Partners Limited Partnership | Institution | 18.9M | 1.10%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 16.0M | 0.93%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 16.0M | 0.92%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Schwab Charles R. · Co-Chairman · Director | 9 Nov 2026 | Open-market sale | −70.8K | $93.01 | $6.58M |
|---|
| Schwab Charles R. · Co-Chairman · Director | 3 Nov 2026 | Open-market sale | −11.7K | $89.21 | $1.04M |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 2 Nov 2026 | Option exercise | +5.0K | $64.10 | $320.5K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 2 Nov 2026 | Open-market sale (10b5-1 plan) | −5.0K | $88.92 | $444.6K |
|---|
| Schwab Charles R. · Co-Chairman · Director | 29 Oct 2026 | Open-market sale | −136K | $89.50 | $12.21M |
|---|
| Schwab Charles R. · Co-Chairman · Director | 28 Oct 2026 | Open-market sale | −66.8K | $88.36 | $5.90M |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 1 Oct 2026 | Option exercise | +5.0K | $41.98 | $209.9K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 1 Oct 2026 | Open-market sale (10b5-1 plan) | −5.0K | $97.80 | $489.0K |
|---|
| Ellis Stephen A · Director | 23 Sep 2026 | Option exercise | +1.9K | $31.48 | $60.38K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 1 Sep 2026 | Open-market sale (10b5-1 plan) | −3.2K | $109.04 | $346.4K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 1 Sep 2026 | Option exercise | +3.2K | $52.05 | $165.4K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 28 Aug 2026 | Open-market sale (10b5-1 plan) | −3.2K | $108.12 | $343.5K |
|---|
| Hathi Neesha · MD, Head Wealth Adv, Bnk, Tst | 28 Aug 2026 | Option exercise | +3.2K | $52.05 | $165.4K |
|---|
| Bettinger Walter W · Co-Chairman · Director | 28 Aug 2026 | Open-market sale | −74.4K | $110.91 | $8.25M |
|---|
| Bettinger Walter W · Co-Chairman · Director | 28 Aug 2026 | Option exercise | +74.4K | $46.81 | $3.48M |
|---|
| Schwab-Pomerantz Carolyn · Director | 26 Aug 2026 | Open-market sale | −9.2K | $109.25 | $1.00M |
|---|
| Bettinger Walter W · Co-Chairman · Director | 24 Aug 2026 | Open-market sale | −176K | $113.49 | $20.00M |
|---|
| Bettinger Walter W · Co-Chairman · Director | 24 Aug 2026 | Option exercise | +176K | $46.81 | $8.25M |
|---|
| Schwab Charles R. · Co-Chairman · Director | 24 Aug 2026 | Open-market sale | −117K | $113.20 | $13.24M |
|---|
| Beatty Jonathan S · MD, Head of Advisor Services | 17 Aug 2026 | Open-market sale | −1.0K | $111.33 | $111.3K |
|---|
| Craig Jonathan M. · MD, Head of Retail Investing | 14 Aug 2026 | Open-market sale (10b5-1 plan) | −21.9K | $111.03 | $2.43M |
|---|
| Craig Jonathan M. · MD, Head of Retail Investing | 14 Aug 2026 | Option exercise | +21.9K | $46.81 | $1.02M |
|---|
| Howard Dennis · MD, Chief Tech, OPS & Data Off | 13 Aug 2026 | Open-market sale (10b5-1 plan) | −2.2K | $110.00 | $241.8K |
|---|
| Schwab Charles R. · Co-Chairman · Director | 12 Aug 2026 | Open-market sale | −46.4K | $108.18 | $5.02M |
|---|
| Schwab Charles R. · Co-Chairman · Director | 11 Aug 2026 | Open-market sale | −46.4K | $107.78 | $5.01M |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
SCHW in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.